2 Patents
- US120775842024Methods of Treating Hla-e-expressing Cancers by Administering Antibodies Which Bind Human Natural Killer Cell Inhibitory Receptor Group 2A (NKG2A)
Bristol-myers Squibb Company
0 cites - US119817342024Nucleic Acid Molecules Encoding Antibodies Which Bind Natural Killer Cell Inhibitory Receptor Group 2A Protein (NKG2A)
Bristol-myers Squibb Company
0 cites